Prosecution Insights
Last updated: October 04, 2026

TriVascular Inc.

3 pending office actions • 0 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

TriVascular Inc. currently has 3 pending office actions. These matters are assigned to 3 distinct examiners, showing that each pending action is being handled by a different individual. The data indicates 0 distinct art units associated with these filings.

ANH TIEU DANG is the busiest examiner for the company, with 1 pending action. This matches the workload seen across the other distinct examiners. Practitioners should note that the portfolio's pending actions are entirely handled by separate examiners, preventing any consolidation of prosecution strategy with a particular official. The absence of multiple art units suggests a specific technical focus for these pending actions. The 1 pending action assigned to ANH TIEU DANG is part of this distributed prosecution effort.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
3
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
2
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (33%)
Double-patenting + other1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
3
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DANG, ANH TIEU 1 65.5% +35.5%
HOLWERDA, KATHLEEN SONNETT 1 68.7% +17.8%
ALEMAN, SARAH WEBB 1 62.1% +23.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19025423 DELIVERY CATHETER FOR ENDOVASCULAR DEVICE HOLWERDA, KATHLEEN SONNETT —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
19225937 BIFURCATED ENDOVASCULAR PROSTHESIS HAVING TETHERED CONTRALATERAL LEG DANG, ANH TIEU —
19025423 DELIVERY CATHETER FOR ENDOVASCULAR DEVICE HOLWERDA, KATHLEEN SONNETT —
18738971 ADVANCED ENDOVASCULAR GRAFT AND DELIVERY SYSTEM ALEMAN, SARAH WEBB —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19225937 BIFURCATED ENDOVASCULAR PROSTHESIS HAVING TETHERED CONTRALATERAL LEG DANG, ANH TIEU — §102§103§112DP Non-Final OA — Pending Jun 02, 2025
19025423 DELIVERY CATHETER FOR ENDOVASCULAR DEVICE HOLWERDA, KATHLEEN SONNETT — §103§112 Non-Final OA — Pending Jan 16, 2025
18738971 ADVANCED ENDOVASCULAR GRAFT AND DELIVERY SYSTEM ALEMAN, SARAH WEBB — §103Other Non-Final OA — Pending Jun 10, 2024

Managing TriVascular Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month